| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0069 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |